Objective Corporation Limited (ASX:OCL): Why Does Its FY27 Earnings Target Differ From FY26 Results?

Sonal Goyal

11 November 2026 05:15 PM AEDT

Objective Corporation Limited (ASX:OCL): Why Does Its FY27 Earnings Target Differ From FY26 Results?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

FY26 Revenue rose 9% to AUD 135 million, while adjusted EBITDA increased 11% to AUD 52 million.
Annualised Recurring Revenue reached AUD 121 million in constant currency.
The company is targeting FY27 adjusted EBITDA above AUD 40 million, below the FY26 result.
FY26 Research and Development Investment totalled AUD 34 million, supporting continued product development.

Objective Corporation Limited (ASX:OCL) develops software used by government agencies and regulated organisations to manage records, information, compliance processes and planning approvals. On 27 August 2026, the company announced FY26 financial results showing higher revenue and earnings, alongside an FY27 adjusted EBITDA target below the latest reported result. The contrast highlights the importance of future investment and cost discipline in the company’s operating outlook.

Objective operates across Regulatory Solutions, Information Intelligence and Planning & Building. Its subscription-based model provides recurring software revenue, although individual Business lines can experience different rates of customer adoption and renewal.

FY26 Financial Performance

Objective reported FY26 revenue of AUD 135 million, up 9% from FY25. Adjusted EBITDA increased 11% to AUD 52 million, and net profit after tax rose 5% to AUD 37 million. Annualised recurring revenue reached AUD 121 million in constant currency.

Operating cash flow was AUD 49 million, equivalent to approximately 94% of adjusted EBITDA. The company reported that subscription software represented all software revenue, while software-as-a-service revenue increased 22%. Its board also declared a final Dividend of 26 cents per share, comprising an 8-cent fully franked component and an 18-cent unfranked component.

Business-Line Trends and Product Investment

Recurring revenue performance differed across Objective’s portfolio. Regulatory Solutions ARR increased 7%, Planning & Building ARR rose 3%, and Information Intelligence ARR declined 5%. The mixed performance means consolidated growth should not be interpreted as uniform expansion across all product groups.

The company invested AUD 34 million in research and development during FY26, representing approximately 30% of software revenue. It reported five-year research and development spending of AUD 146 million. This expenditure supports product capabilities and longer-term opportunities, but the timing and financial return from product investment are not assured.

FY27 Target and Execution Considerations

Objective is targeting FY27 adjusted EBITDA above AUD 40 million, compared with AUD 52 million achieved in FY26. The target is not an actual result and indicates that near-term Earnings may be lower even as management pursues larger government technology opportunities.

The company has outlined plans to refine its sales approach, maintain cost discipline and assess acquisitions. Key monitorables include ARR trends, particularly in Information Intelligence, progress on larger contracts and the relationship between research expenditure and earnings. Public-sector procurement cycles and Acquisition integration are additional operational risks.

Key Insights

Objective’s FY26 revenue and recurring income increased, but its FY27 adjusted EBITDA target is lower than the latest result. Business-line ARR and investment outcomes will be important indicators.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.